Sartorius Stedim stock at EUR 215.30, 4.3 percent below its high

Published on 10/12/2026 at 14:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius Stedim stock costs EUR 215.30 on October 12, 2026, below its EUR 225.00 high. Market cap is EUR 21.0 billion.

Key points in brief

Sartorius Stedim stock was trading at EUR 215.30 at Lang & Schwarz on October 12, 2026.
The price was 4.30 percent below the EUR 225.00 52-week high.
Market capitalization stood at EUR 21.0 billion and the P/E ratio was 70.99.
AlphaValue raised its target to EUR 253, while Goldman Sachs raised its target to EUR 223.
The company scheduled its 9M 2026 results conference call for October 22, 2026.

Fotorealistische Aufnahme einer sterilen Bioprozessanlage mit Einwegbeuteln und Bioreaktoren — Sartorius Stedim Biotech produziert sterile Einwegbeutel und Bioreaktoren für Biopharma-Hersteller weltweit, ISIN FR0013154002, Illustration mit AI erstellt.

Sartorius Stedim stock (ISIN FR0013154002) was trading at EUR 215.30 at Lang & Schwarz on October 12, 2026 at 2:23 p.m. CEST, 4.30 percent below the EUR 225.00 52-week high. The price places the biopharmaceutical equipment maker near the upper end of its EUR 150.00 to EUR 225.00 52-week range.

Price remains near yearly high

The EUR 225.00 high and EUR 150.00 low are the current range markers, leaving the stock 43.53 percent above its 52-week low. Market capitalization stood at EUR 21.0 billion on October 12, 2026, while the P/E ratio was 70.99.

Trading volume for Sartorius Stedim was 9,263 shares in the latest finance snapshot at 12:12 p.m. UTC on October 12, 2026. That activity compares with an average volume of 90,440 shares, although the home-market quote and the Lang & Schwarz price represent different trading venues.

Analyst targets set valuation context

AlphaValue confirmed its accumulate recommendation and raised its price target from EUR 238 to EUR 253 on October 8, 2026. According to MarketScreener, that target lies 17.53 percent above the Lang & Schwarz price.

Goldman Sachs raised its target from EUR 208 to EUR 223 on October 1, 2026 and kept its Buy rating. The report, carried by FinanzNachrichten, places the target 3.57 percent above the current euro price.

Comparison with peers

Sartorius Stedim: , P/E 70.99, market capitalization EUR 21.0 billion
Thermo Fisher Scientific (NYSE, USD): plus 0.93 percent, P/E 35.40, market capitalization USD 243.3 billion
Danaher (NYSE, USD): plus 1.11 percent, P/E 39.05, market capitalization USD 154.6 billion

Next results arrive October 22

Sartorius Stedim has scheduled its conference call for the nine-month 2026 results on October 22, 2026 at 1:00 p.m. CEST, according to the company's Sartorius Stedim Biotech investor-relations page. That date gives the market its next scheduled operating checkpoint after the first-half 2026 reporting period.

Lang & Schwarz quote in trading

Sartorius Stedim was trading at EUR 215.30 at Lang & Schwarz on October 12, 2026 at 2:23 p.m. CEST, with the price 4.30 percent below its EUR 225.00 52-week high. The Euronext Paris listing uses ticker DIM and the company operates in the health care sector.
The further course of trading is shown by the continuously updated real-time quote of Sartorius Stedim stock.